/Companies

Apollo

Pittsburgh, US · Founded 2017 · 19 employees on LinkedIn · 11 known investors

Find your way into Apollo

Sign up to see every warm intro you have to Apollo

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Apollo team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Apollo Neuro makes a wearable device that delivers gentle vibrations ("SmartVibes") intended to balance the autonomic nervous system, aiming to reduce stress, improve sleep, focus, and recovery. Developed by physicians and neuroscientists and backed by clinical research, the consumer product is worn on the wrist, ankle, or clipped to clothing and paired with a subscription app.

Founders & leadership

Apollo was founded in 2017 by Kathryn Fantauzzi and Dr. David Rabin MD, PhD.

KFKathryn Fantauzzi
Kathryn FantauzziCo-Founder & CEOKathryn Fantauzzi holds a B.A. from Smith College and an M.P.A. from Rockefeller College of Public Affairs and Policy. She previously worked on tech commercialization initiatives at the New York State Energy Research & Development Authority, overseeing funding programs before joining a University of Pittsburgh research team in 2016 to help advance Apollo Neuro, a neuroscience-based wearable technology, which she then founded as a company and brought to market in 2020.
DDDr. David Rabin MD, PhD
Dr. David Rabin MD, PhDCo-founder; neuroscientist and board-certified psychiatrist

Investors · 11

Also in the syndicate · 2

GoogleleadNoetic Fundlead

Funding

SEC filings, press & company announcements

$23.8M disclosed across 5 of 8 rounds · 2018–2026

▶$500KraisedApr 2024 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gary JohnsonDirector
  • Alan CannistraroExecutive Officer, Director
  • Kathryn FantauzziExecutive Officer, Director
  • David RabinExecutive Officer, Director
  • Sa'ad ShahDirector
Offering amount
$2M
Amount sold
$500K
First sale
Apr 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.3MraisedApr 2024 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Sa'ad ShahDirector
  • Alan CannistraroExecutive Officer, Director
  • Kathryn FantauzziExecutive Officer, Director
  • Gary JohnsonDirector
  • David RabinExecutive Officer, Director
Offering amount
$15M
Amount sold
$9.3M
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8MraisedSep 2021 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kathryn FantauzziExecutive Officer, Director, Promoter
Offering amount
$15M
Amount sold
$8M
Sales commissions
$84.8K
Placement agents
Melvin Pirchesky
First sale
May 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.9MraisedFeb 2021 · 51 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kathryn FantauzziExecutive Officer, Director, Promoter
Offering amount
$5.9M
Amount sold
$5.9M
Sales commissions
$80K
Placement agents
Boustead Securities, LLC
First sale
Jun 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$100KraisedMar 2018 · 1 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kathryn FantauzziExecutive Officer, Director, Promoter
Offering amount
$250K
Amount sold
$100K
First sale
Mar 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
Department of DefenseSpecial Operations CommandPhase I2018$149.8K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Apollo do?
Apollo Neuro makes a wearable device that delivers gentle vibrations ("SmartVibes") intended to balance the autonomic nervous system, aiming to reduce stress, improve sleep, focus, and recovery. Developed by physicians and neuroscientists and backed by clinical research, the consumer product is worn on the wrist, ankle, or clipped to clothing and paired with a subscription app.
Who founded Apollo?
Apollo was founded by Kathryn Fantauzzi, Dr. David Rabin MD, PhD in 2017.
Who are Apollo's investors?
Apollo's investors include ID8 Investments, Noetic, Portfolia, B Capital, Bain Capital Ventures, Nexus Venture Partners, SeaX Ventures, Sequoia Capital and 1 more.
How much funding has Apollo raised?
Apollo has disclosed $23.8M raised across 5 of its 8 known rounds.
Where is Apollo headquartered?
Apollo is headquartered in Pittsburgh, US.